Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction
Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction: A Randomized Controlled Trial
Sponsor: University of Kansas Medical Center
Terminated
recruitment stalled
Other terminated trials from University of Kansas Medical Center
- Benign Prostatic Hyperplasia · Jan 2025
- Fetal Macrosomia · Sep 2024
- Benign Prostatic Hyperplasia · Aug 2024
- Prostate Adenocarcinoma · Phase EARLY_PHASE1 · Nov 2023
- Neuropathy · Phase NA · Jul 2022
See all terminations from University of Kansas Medical Center
Listed as NCT04347122, this PHASE4 trial focuses on Musculoskeletal Cancer and Sarcoma,Soft Tissue and remains terminated or withdrawn. Sponsored by University of Kansas Medical Center, it has been updated 8 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Jun 2025 — Present [monthly]
Terminated PHASE4
Status: Completed → Terminated
-
Sep 2024 — Jun 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Dec 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jun 2022 — Dec 2023 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Jun 2021 — Jun 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE4
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE4
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Kansas Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .